CompoAtlas

Fit Caps

Supplement recorded in Open Food Facts

Fit Caps (Superfood Natural Mojo): ingredient list recorded on 20 March 2026. Food supplement : 2 vitamins or minerals, 2 plantes, 11 other ingredients. The daily dose is not stated: the quantities read cannot establish whether a daily dose is met or exceeded. See the references below.

This collaborative Open Food Facts record is dated: the date relates to an update of the record, rather than a formula check. The formula may have changed. Check the packaging. This product is not necessarily declared in France: Compl'Alim declarations are separate.

Open Food Facts: food supplements with a barcode and an ingredient list, retrieved 15 November 2026.

Data “Open Food Facts and its contributors”, licensed under ODbL 1.0; derived table distributed under the same licence.

Brand
Superfood Natural Mojo
Barcode
4251347600491
Countries listed in the record
France
Record date
20 March 2026

Open Food Facts record; Compl'Alim declarations in France.

Ingredient list as published

Agent de charge: hydroxypropylméthylcellulose, extrat de thé vert (14,4%), L-carnitine tartrate (13,2%), bitartrate de choline (12,3%), extrait de café vert, extrait de Garcinia Cambogia, charge: cellulose microcristalline, extrait de piment (6,0%), extrait de Mate (5,4%), Agent de séparation: Dioxyde de silicium et stéarate de magnésium, citrate de zinc nicotinamide, extrait de poivre, de calcium, de D-pantothénate, mononitrate de thiamine.

Open Food Facts: food supplements with a barcode and an ingredient list, retrieved 15 November 2026.

Data “Open Food Facts and its contributors”, licensed under ODbL 1.0; derived table distributed under the same licence.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • extrait de Garcinia Cambogia
    Read the warning, when it applies and the studies cited

    MALABAR TAMARIND - GARCINIA GUMMI-GUTTA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder (HC 2025).

    Sources cited by Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Garcinia gummi-gutta and Hydroxycitric Acid - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1755272782909
    • SC 2025 : Santé Canada : Résumé de l'examen de l'innocuité - Garcinia gummi-gutta et acide hydroxycitrique - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1755272782909

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Sources cited by Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Garcinia gummi-gutta and Hydroxycitric Acid - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1755272782909
    • SC 2025 : Santé Canada : Résumé de l'examen de l'innocuité - Garcinia gummi-gutta et acide hydroxycitrique - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1755272782909

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Sources cited by Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Garcinia gummi-gutta and Hydroxycitric Acid - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1755272782909
    • SC 2025 : Santé Canada : Résumé de l'examen de l'innocuité - Garcinia gummi-gutta et acide hydroxycitrique - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1755272782909

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (HC 2010).

    Sources cited by Health Canada (2)
    • HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
    • SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf

    Health Canada monograph dated 26 September 2025

  • extrait de piment (6,0%)
    Read the warning, when it applies and the studies cited

    CAYENNE - CAPSICUM ANNUUM Oral

    Cautions and warnings

    Condition of application: All products.

    Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).

    Sources cited by Health Canada (2)
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Condition of application: Digestion; Peripheral circulation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical

    Cautions and warnings

    Condition of application: All products.

    For external use only (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Known adverse reactions

    Condition of application: All products.

    Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).

    Sources cited by Health Canada (5)
    • APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
    • Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
    • McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomised trial
    • Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematic review

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Download the derived table under ODbL 1.0 (photo transcriptions under CC BY-SA 3.0).

Composition analysis

Food supplement: the checks below follow French and EU rules and are in French.

Food supplement : 2 vitamins or minerals, 2 plantes, 11 other ingredients. The daily dose is not stated: the quantities read cannot establish whether a daily dose is met or exceeded. See the references below.

For a complete answer, add the daily dose stated on the packaging to the end of the text (for example, ‘1 capsule per day’) and the quantity table (‘per 2 capsules: vitamin C 80 mg…’), or paste the product page link in the ‘link’ field below: we read the list, table and dose from it.

A food supplement is read differently from a cosmetic: daily doses and plants are what matter. References: maximum dose per supplement in France (Order of 9 May 2006, not revised since November 2006), EFSAEuropean Food Safety Authority. safety limit for adults, list of authorised plants (Order of 24 June 2014).

Each row: the printed name, what we recognise (click for its page), the dose read, then its role in the product and the references that apply.

On the labelRecognised asDose readWhat to know
Agent de charge: hydroxypropylméthylcelluloseBulking agent: adds volume without providing much energynot statedBulking agent: adds volume without providing much energy.
extrat de thé vert (14,4%)Other ingredient, not identified in our sourcesnot statedno reference
L-carnitine tartrate (13,2%)Other ingredient, not identified in our sourcesnot statedIn France, la quantité présente dans la portion journalière recommandée ne doit pas dépasser 2 000 mg. Toutes les formes d'apport contiennent une carnitine de haute pureté chimique (99 % de l'énantiomère L) (Order of 26 September 2016): the mass of a salt or ester is not the mass of the substance.
bitartrate de choline (12,3%)Other ingredient, not identified in our sourcesnot statedno reference
extrait de café vertOther ingredient, not identified in our sourcesnot statedno reference
extrait de Garcinia CambogiaGarcinia gummi-gutta (L.) Roxb.not statedGarcinia gummi-gutta (L.) Roxb. is not on the plant list of the Order of 24 June 2014: this is not a prohibition (a product legally sold in another Union country may contain it).
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
charge: cellulose microcristallineOther ingredient, not identified in our sourcesnot statedno reference
extrait de piment (6,0%)Capsicum annuum L.not statedCapsicum annuum L. is on the list of plants allowed in food supplements (Order of 24 June 2014).
extrait de Mate (5,4%)Other ingredient, not identified in our sourcesnot statedno reference
Agent de séparation: Dioxyde de silicium et stéarate de magnésiumOther ingredient, not identified in our sourcesnot statedno reference
citrate de zinc nicotinamideOther ingredient, not identified in our sourcesnot statedno reference
extrait de poivreOther ingredient, not identified in our sourcesnot statedno reference
calciumCalciumnot statedDose not read: compare the one on the label with the references on the nutrient’s page.
D-pantothénateOther ingredient, not identified in our sourcesnot statedno reference
mononitrate de thiamineVitamine B1 (thiamine)not statedDose not read: compare the one on the label with the references on the nutrient’s page.

No dose reference in our sources for this name: it is not linked to any vitamin, mineral, plant or additive on our lists.

NRV: nutrient reference value, the daily reference intake for an adult set by Regulation (EU) No 1169/2011. Maximum dose in France: daily ceiling for a food supplement (Order of 9 May 2006). EFSA limit: intake not to be exceeded each day over the long term, including food.

During pregnancy or breastfeeding, or when taking medication, ask a doctor or pharmacist before taking a supplement.

Brand : Superfood Natural Mojo

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Fit Caps (Superfood Natural Mojo): composition and ingredients”, https://compoatlas.com/en/supplements/barcodes/4251347600491-fit-caps-superfood-natural-mojo, updated 20 March 2026.

Enter to analyse, Shift+Enter for a new line